tiprankstipranks
Advertisement
Advertisement
Fusen Pharmaceutical Gains Approval for Nicardipine Hydrochloride Injection
PremiumCompany AnnouncementsFusen Pharmaceutical Gains Approval for Nicardipine Hydrochloride Injection
4M ago
Fusen Pharmaceutical’s New Hypertension Drug Gains Approval in China
Premium
Company Announcements
Fusen Pharmaceutical’s New Hypertension Drug Gains Approval in China
5M ago
Fusen Pharmaceutical’s Enzalutamide Soft Capsule Approved for Prostate Cancer Treatment in China
Premium
Company Announcements
Fusen Pharmaceutical’s Enzalutamide Soft Capsule Approved for Prostate Cancer Treatment in China
6M ago
Fusen Pharmaceutical Announces Strategic Disposal of Subsidiary
PremiumCompany AnnouncementsFusen Pharmaceutical Announces Strategic Disposal of Subsidiary
7M ago
Fusen Pharmaceutical Gains Approval for New Diabetes Treatment
Premium
Company Announcements
Fusen Pharmaceutical Gains Approval for New Diabetes Treatment
7M ago
Fusen Pharmaceutical Reports Significant Revenue Decline in H1 2025
Premium
Company Announcements
Fusen Pharmaceutical Reports Significant Revenue Decline in H1 2025
8M ago
Fusen Pharmaceutical Reports Significant Financial Decline in 2024
PremiumCompany AnnouncementsFusen Pharmaceutical Reports Significant Financial Decline in 2024
1y ago
Fusen Pharmaceutical Postpones Board Meeting to Finalize Annual Results
Premium
Company Announcements
Fusen Pharmaceutical Postpones Board Meeting to Finalize Annual Results
1y ago
Fusen Pharmaceutical Issues Profit Warning Amid Increased Losses
Premium
Company Announcements
Fusen Pharmaceutical Issues Profit Warning Amid Increased Losses
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100